Skip to content
View in the app

A better way to browse. Learn more.

Thailand News and Discussion Forum | ASEANNOW

A full-screen app on your home screen with push notifications, badges and more.

To install this app on iOS and iPadOS
  1. Tap the Share icon in Safari
  2. Scroll the menu and tap Add to Home Screen.
  3. Tap Add in the top-right corner.
To install this app on Android
  1. Tap the 3-dot menu (⋮) in the top-right corner of the browser.
  2. Tap Add to Home screen or Install app.
  3. Confirm by tapping Install.

Molnupiravir granted provisional approval in Australia

Featured Replies

https://www.9news.com.au/national/coronavirus-treatment-drug-provisional-approval-tga-australia-molnupiravir-merck/0446d9bf-4a17-4fd9-96ef-855254e39c5d

Go to Oz News--Scroll (right) to number ten

 

6 hours ago---

An antiviral drug developed to treat influenza has been granted provisional approval in Australia to treat coronavirus.

Molnupiravir, made by Merck Sharp and Dohme (MSD), will be considered for treatment for COVID-19 in adults.

The drug, taken orally, slows the virus's replication within the human body, effectively stopping the disease from fully taking hold.

https://www.afr.com/policy/health-and-education/new-covid-19-drug-steps-closer-to-approval-in-australia-20210810-p58hns

 

 

--------------------------------------------------

https://chulalongkornhospital.go.th/kcmh/line/molnupiravir-ยาต้านไวรัสทดลองแนวท/

Source:
Prof. Kulkanya Chokphaiboonkit, MD.
Faculty of Medicine Siriraj Hospital Mahidol University,
Prof. Dr. Yong Phuworawan,
Chulalongkorn Hospital, Thai Red Cross Society and the Faculty of Medicine. Chulalongkorn University
Asst. Prof. Dr. Kamthorn Malatham,
Faculty of Medicine Ramathibodi Hospital Mahidol University.
 

https://www.merck.com/news/interim-results-from-phase-2-3-studies-of-molnupiravir-an-investigational-oral-antiviral-therapeutic-for-mild-to-moderate-covid-19-presented-at-the-european-congress-of-clinical-microbiology-i/

 

"Shows promise" seems to be current description.

 

Mild cases, at home. 

 

Is said to inhibit replication of the virus in the body. 

 

Not seeing much detail about the science so far.

  • Author
51 minutes ago, mtls2005 said:

Not seeing much detail about the science so far.

The Chulalongkorn University which talked about it 2 months ago--gives more details, Gives a 5 step chart---but all in Thai.... .. My interpreter (wife) took one look at it and said    "To Hard-give me headache"   https://chulalongkornhospital.go.th/kcmh/line/molnupiravir-ยาต้านไวรัสทดลองแนวท/

Just right click and translate.

 

Although nothing there:

 

1. Molnupiravir (molnupiravir) is an antiviral oral tablet. Developed for the treatment of influenza
2. Studies have shown that it is effective against many coronaviruses, such as SARS, MERS and COVID-19.
3. Molnupiravir is currently has status as an antiviral drug test It is undergoing Phase 3 clinical trials in humans and is considering for approval by the US Food and Drug Administration.
4. After this, if the results of the study showed that the drug was effective in reducing the severity of the disease and reduce the likelihood of death a chance to be approved as an emergency drug for the treatment of COVID-19
5. Preventing the spread of COVID-19 The best thing right now is vaccination against COVID-19. together with self-defense measures in a new way of life (New Normal)

Create an account or sign in to comment

Recently Browsing 0

  • No registered users viewing this page.

Account

Navigation

Search

Search

Configure browser push notifications

Chrome (Android)
  1. Tap the lock icon next to the address bar.
  2. Tap Permissions → Notifications.
  3. Adjust your preference.
Chrome (Desktop)
  1. Click the padlock icon in the address bar.
  2. Select Site settings.
  3. Find Notifications and adjust your preference.